表紙
市場調査レポート

世界のqPCR(リアルタイムポリメラーゼ連鎖反応)およびdPCR(デジタルポリメラーゼ連鎖反応)市場

Global qPCR and dPCR Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 322829
出版日 ページ情報 英文 115 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
世界のqPCR(リアルタイムポリメラーゼ連鎖反応)およびdPCR(デジタルポリメラーゼ連鎖反応)市場 Global qPCR and dPCR Market 2015-2019
出版日: 2015年01月07日 ページ情報: 英文 115 Pages
概要

世界のqPCR(リアルタイムポリメラーゼ連鎖反応)およびdPCR(デジタルポリメラーゼ連鎖反応)市場は2014年から2019年にかけて9.67%のCAGRで成長する見通しです。

当レポートでは、世界のqPCRおよびdPCR市場について調査し、アプリケーション、技術、製品タイプおよび地域別の市場規模と予測、市場影響因子および競合情勢の分析を提供しており、主要ベンダーの分析を交え、お届け致します。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 概要

第7章 市場情勢

  • 市場概要
  • 市場規模・予測
  • 米国におけるqPCRおよびdPCR市場
  • 欧州におけるqPCRおよびdPCR市場
  • 日本におけるqPCRおよびdPCR市場
  • ファイブフォース分析

第8章 市場区分:アプリケーション別

第9章 市場区分:技術別

  • 世界のqPCR市場
    • 市場規模と予測
  • 世界のdPCR市場

第10章 市場区分:製品タイプ別

  • 世界のqPCRおよびdPCR消耗品市場
    • 市場規模と予測
  • 世界のqPCRおよびdPCR装置市場
  • 世界のqPCRおよびdPCRサービス市場

第11章 地理区分

  • 南北アメリカにおけるqPCRおよびdPCR市場
    • 市場規模と予測
  • EMEA(欧州・中東・アフリカ)におけるqPCRおよびdPCR市場
  • APAC(アジア太平洋地域)におけるqPCRおよびdPCR市場

第12章 購入基準

第13章 市場成長因子

第14章 成長因子とその影響

第15章 市場の課題

第16章 成長因子と課題の影響

第17章 市場動向

第18章 動向とその影響

第19章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • M & A
  • ベンダー分析
  • その他の有力ベンダー

第20章 主要ベンダーの分析

  • Abbott Laboratories
    • 主要データ
    • 事業概要
    • 事業区分:収益別
    • 地域区分:収益別
    • 事業戦略
    • 主要情報
    • SWOT分析
  • Agilent Technologies
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Qiagen

第21章 関連レポート

図表一覧

目次
Product Code: IRTNTR5088

About qPCR and dPCR

qPCR (Real-time Polymerase Chain Reaction) and dPCR (Digital Polymerase Chain Reaction) are the advanced PCR technologies that provide higher accuracy and reproducibility in nucleic acids amplification and analysis. qPCR allows amplification and quantification of a targeted DNA molecule in real-time. While dPCR is an advanced PCR that allows direct quantification and amplification of nucleic acids including RNA, DNA, cDNA, methylated DNA. It does not rely on the number of amplification cycles to measure the initial sample amount and provides absolute quantification of nucleic acid. qPCR and dPCR need a small amount of sample and provide higher accuracy, sensitivity, and efficiency than conventional PCR. These technologies are widely used in various research and diagnostic applications such as rare allele detection, quantification of nucleic acid standards, viral load quantification, NGS libraries quantification, low-fold copy number discrimination, and enrichment and separation of mixtures.

TechNavio's analysts forecast the Global qPCR and dPCR market to grow at a CAGR of 9.67 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of Global qPCR and dPCR market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from sales of qPCR and dPCR products: qPCR and dPCR consumables, qPCR and dPCR instruments, and qPCR and dPCR services. It has a broad range of applications in various fields including:

  • Drug Discovery and Development
  • Clinical Diagnostics
  • Research
  • Others

Also, the two predominant technologies, qPCR and dPCR, are used in research, drug discovery and development and diagnostics applications.

TechNavio's report, Global qPCR and dPCR Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC region and the EMEA region; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion on the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Agilent Technologies
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Qiagen
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Advanced Molecular Systems
  • Affymetrix
  • altona Diagnostics
  • Anachem
  • Analytik Jena
  • ArcticZymes
  • Becton Dickinson
  • Bibby Scientific
  • bioMerieux
  • Biosearch Technologies
  • BIOTECON Diagnostics
  • Biotools B&M Labs
  • Central Biotechnology Services
  • Cepheid
  • Eppendorf
  • Eurogentec (a part of Kaneka Corporation)
  • Exiqon
  • Fast-track diagnostics
  • Fluidigm
  • Fluorogenics
  • Formulatrix
  • Harvard Bioscience
  • Illumina
  • Integrated DNA Technologies
  • Integromics
  • Kapa Biosystems
  • Kyratec
  • Ocimum Biosolutions
  • Optigene
  • PCR Biosystems
  • PerkinElmer
  • Primerdesign
  • Promega
  • Quidel
  • RainDance Technologies
  • Sacace Biotechnologies
  • Takaro Bio
  • TATAA Biocenter
  • Tecan
  • WaferGen Biosystems

Market Driver

  • Advances in Technology
  • For a full, detailed list, view our report

Market Challenge

  • Intense Competition among Vendors
  • For a full, detailed list, view our report

Market Trend

  • Adoption of dPCR
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Overview

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. qPCR and dPCR Market in US
    • 07.3.1. Market Size and Forecast
  • 07.4. qPCR and dPCR Market in Europe
    • 07.4.1. Market Size and Forecast
  • 07.5. qPCR and dPCR Market in Japan
    • 07.5.1. Market Size and Forecast
  • 07.6. Five Forces Analysis

08. Market Segmentation by Application

09. Market Segmentation by Technology

  • 09.1. Global qPCR Market
    • 09.1.1. Market Size and Forecast
  • 09.2. Global dPCR Market
    • 09.2.1. Market Size and Forecast

10. Market Segmentation by Product Type

  • 10.1. Global qPCR and dPCR Consumables Market
    • 10.1.1. Market Size and Forecast
  • 10.2. Global qPCR and dPCR Instruments Market
    • 10.2.1. Market Size and Forecast
  • 10.3. Global qPCR and dPCR Services Market
    • 10.3.1. Market Size and Forecast

11. Geographical Segmentation

  • 11.1. qPCR and dPCR Market in Americas
    • 11.1.1. Market Size and Forecast
  • 11.2. qPCR and dPCR Market in EMEA Region
    • 11.2.1. Market Size and Forecast
  • 11.3. qPCR and dPCR Market in APAC Region
    • 11.3.1. Market Size and Forecast

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Vendor Analysis 2014
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. Abbott Laboratories
    • 20.1.1. Key Facts
    • 20.1.2. Business Overview
    • 20.1.3. Business Segmentation by Revenue
    • 20.1.4. Business Segmentation by Revenue 2011 and 2012
    • 20.1.5. Geographical Segmentation by Revenue
    • 20.1.6. Business Strategy
    • 20.1.7. Key Information
    • 20.1.8. SWOT Analysis
  • 20.2. Agilent Technologies
    • 20.2.1. Key Facts
    • 20.2.2. Business Overview
    • 20.2.3. Business Segmentation by Revenue 2013
    • 20.2.4. Business Segmentation by Revenue 2012 and 2013
    • 20.2.5. Geographical Segmentation by Revenue 2013
    • 20.2.6. Business Strategy
    • 20.2.7. Recent Developments
    • 20.2.8. SWOT Analysis
  • 20.3. Bio-Rad Laboratories
    • 20.3.1. Key Facts
    • 20.3.2. Business Overview
    • 20.3.3. Business Segmentation
    • 20.3.4. Business Strategy
    • 20.3.5. Business Segmentation by Revenue
    • 20.3.6. Business Segmentation by Revenue 2011 and 2012
    • 20.3.7. Geographical Segmentation by Revenue 2012
    • 20.3.8. Key Developments
    • 20.3.9. SWOT Analysis
  • 20.4. F. Hoffmann-La Roche
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Business Segmentation
    • 20.4.4. Geographical Segmentation by Revenue 2013
    • 20.4.5. Business Strategy
    • 20.4.6. Key Information
    • 20.4.7. SWOT Analysis
  • 20.5. Thermo Fisher Scientific
    • 20.5.1. Key Facts
    • 20.5.2. Business Overview
    • 20.5.3. Business Segmentation
    • 20.5.4. Product Segmentation by Revenue
    • 20.5.5. Sales Segmentation
    • 20.5.6. Business Strategy
    • 20.5.7. Key Information
    • 20.5.8. SWOT Analysis
  • 20.6. Qiagen
    • 20.6.1. Key Facts
    • 20.6.2. Business Overview
    • 20.6.3. Product Segmentation by Revenue 2013
    • 20.6.4. Product Segmentation by Revenue 2012 and 2013
    • 20.6.5. Geographical Segmentation by Revenue 2013
    • 20.6.6. Business Strategy
    • 20.6.7. Recent Developments
    • 20.6.8. SWOT Analysis

21. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Advantages of qPCR
  • Exhibit 3: Advantages of dPCR
  • Exhibit 4: Global qPCR and dPCR Market 2014-2019 (US$ million)
  • Exhibit 5: qPCR and dPCR Market in US 2014-2019 (US$ million)
  • Exhibit 6: qPCR and dPCR Market in Europe 2014-2019 (US$ million)
  • Exhibit 7: qPCR and dPCR Market in Japan 2014-2019 (US$ million)
  • Exhibit 8: Segmentation of Global qPCR and dPCR Market by Application
  • Exhibit 9: Segmentation of Global qPCR and dPCR Market by Application 2014
  • Exhibit 10: Segmentation of Global qPCR and dPCR Market by Technology
  • Exhibit 11: Segmentation of Global qPCR and dPCR Market by Application 2014 and 2019
  • Exhibit 12: Segmentation of Revenue (US$ million) and CAGR of Global qPCR and dPCR Market by Technology 2014 and 2019
  • Exhibit 13: Global qPCR Market 2014-2019 (US$ million)
  • Exhibit 14: Global dPCR Market 2014-2019 (US$ million)
  • Exhibit 15: Segmentation of Global qPCR and dPCR Market by Technology 2014-2019 (US$ million)
  • Exhibit 16: Segmentation of Global qPCR and dPCR Market by Technology 2014-2019
  • Exhibit 17: Segmentation of Global qPCR and dPCR Market by Product Type
  • Exhibit 18: Segmentation of Global qPCR and dPCR Market by Product Type 2014 and 2019
  • Exhibit 19: Segmentation of Revenue (US$ million) and CAGR of Global qPCR and dPCR Market by Product Type 2014 and 2019
  • Exhibit 20: Global qPCR and dPCR Consumables Market 2014-2019 (US$ million)
  • Exhibit 21: Global qPCR and dPCR Instruments Market 2014-2019 (US$ million)
  • Exhibit 22: Global qPCR and dPCR Services Market 2014-2019 (US$ million)
  • Exhibit 23: Segmentation of Global qPCR and dPCR Market by Product Type 2014-2019 (in million)
  • Exhibit 24: Segmentation of Global qPCR and dPCR Market by Product Type 2014-2019
  • Exhibit 25: Segmentation of Global qPCR and dPCR Market by Geography 2014 and 2019
  • Exhibit 26: Segmentation of Revenue (US$ million) and CAGR of Global qPCR and dPCR Market by Geography 2014 and 2019
  • Exhibit 27: qPCR and dPCR Market in Americas 2014-2019 (US$ million)
  • Exhibit 28: qPCR and dPCR Market in EMEA Region 2014-2019 (US$ million)
  • Exhibit 29: qPCR and dPCR Market in APAC Region 2014-2019 (US$ million)
  • Exhibit 30: Global qPCR and dPCR Market Segmentation by Geography 2014-2019 (US$ million)
  • Exhibit 31: Global qPCR and dPCR Market Segmentation by Geography 2014-2019
  • Exhibit 32: Buying Criteria in Global qPCR and dPCR Market
  • Exhibit 33: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 34: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 35: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 36: Agilent Technologies: Business Segmentation by Revenue 2013
  • Exhibit 37: Agilent Technologies: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 38: Agilent Technologies: Geographical Segmentation by Revenue 2013
  • Exhibit 39: Bio-Rad: Business Segmentation
  • Exhibit 40: Bio-Rad: Business Segmentation by Revenue 2012
  • Exhibit 41: Bio-Rad: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 42: Bio-Rad: Geographical Segmentation by Revenue 2012
  • Exhibit 43: F. Hoffmann-La Roche: Business Segmentation 2013
  • Exhibit 44: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 45: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals)
  • Exhibit 46: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics)
  • Exhibit 47: Thermo Fisher Scientific: Business Segmentation by Revenue 2013
  • Exhibit 48: Thermo Fisher Scientific: Product Segmentation by Revenue 2013
  • Exhibit 49: Thermo Fisher Scientific: Sales by Geography 2013
  • Exhibit 50: Qiagen: Product Segmentation by Revenue 2013
  • Exhibit 51: Qiagen: Product Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 52: Qiagen: Geographical Segmentation by Revenue 2013
Back to Top